Biogen Newsroom

Needham Reiterates Buy on Biogen, Maintains $294 Price Target

BenzingaJun 28 17:33

RBC Capital Reiterates Outperform on Biogen, Maintains $317 Price Target

BenzingaJun 27 21:58

Biogen Analyst Ratings

BenzingaJun 26 23:08

RBC Capital Reiterates Outperform on Biogen, Maintains $317 Price Target

BenzingaJun 26 23:08

Wedbush Adjusts Price Target on Biogen to $215 From $219

MT NewswiresJun 6 19:12

Biogen Analyst Ratings

BenzingaJun 5 22:40

Analysts' Opinions Are Mixed on These Healthcare Stocks: Gilead Sciences (GILD), Biogen (BIIB) and Argenx Se (ARGX)

TipRanksMay 31 11:04

Royal Bank of Canada: Biogen (BIIB.US) rating was reaffirmed and adjusted from superior to superior market rating, with a target price of $317.00.

Zhitong FinanceMay 29 22:02

Biogen Analyst Ratings

BenzingaMay 29 22:00

RBC Capital Reiterates Outperform on Biogen, Maintains $317 Price Target

BenzingaMay 29 22:00

RBC Capital Sticks to Its Buy Rating for Biogen (BIIB)

TipRanksMay 29 18:48

Analysts Offer Insights on Healthcare Companies: Inari Medical (NARI), Biogen (BIIB) and SOPHiA GENETICS (SOPH)

TipRanksMay 28 18:54

Biogen's Strategic Diversification and Financial Strategy Garner Outperform Rating

TipRanksMay 24 13:55

Strategic Acquisitions and Clinical Catalysts Bolster Biogen's Buy Rating

TipRanksMay 24 13:50

Biogen (BIIB) Gets a Buy From Oppenheimer

TipRanksMay 23 20:02

Analysts' Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB) and Incyte (INCY)

TipRanksMay 23 19:15

HC Wainwright & Co. : Biogen (BIIB.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $300.00.

Zhitong FinanceMay 23 18:11

Biogen Analyst Ratings

BenzingaMay 23 18:10

Wedbush Raises Biogen Price Target to $219 From $215, Maintains Neutral Rating

MT NewswiresMay 22 21:50

Biogen Analyst Ratings

BenzingaMay 22 21:40